fda warning letters compounded semaglutide tirzepatide september 2025 issued 25 to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of Diabetes advocacy group discourages use

Most of the subjects included in the available RCTs are PCOS patients with severe obesity, which do not reflect the entire clinical spectrum of PCOS encountered in clinical practice

Furthermore, these studies have identified a threshold effect in male subjects, wherein fasting GLP-1 levels appeared to confer a protective effect against cancer risk [6]

They work by slowing stomach emptying, curbing food noise and cravings, and improving metabolic response, but they also introduce a unique routine of weekly shots, fluctuating medication levels and side effects that ebb and flow over the course of the week

So, if your doctor told you to expect a pink color, you are good to go